Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 388 shares at $6.41 ($2K) on 2023-01-06, disclosed to the SEC on 2023-01-10.
Open-market sale of $2k VYGR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-11 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |